Eliciting neutralizing antibodies against the membrane proximal external region of HIV-1 Env by chimeric live attenuated influenza A virus vaccines

被引:7
|
作者
Zang, Yang [1 ]
Du, Dongchuan [1 ]
Li, Na [1 ]
Su, Weiheng [1 ]
Liu, Xintao [3 ]
Zhang, Yan [1 ]
Nie, Jianhui [4 ]
Wang, Youchun [4 ]
Kong, Wei [1 ,2 ]
Jiang, Chunlai [1 ,2 ]
机构
[1] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China
[2] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130012, Peoples R China
[3] Changchun BCHT Biotechnol Co, Changchun, Peoples R China
[4] Natl Inst Food & Drug Control, Dept Cell Biol, Key Lab, Minist Hlth Res Qual & Standardizat Biotech Prod, Beijing 100050, Peoples R China
关键词
MPER; Attenuated influenza A virus; HA; HIV-1; vaccine; MONOCLONAL-ANTIBODIES; TYPE-1; ANTIBODY; BROAD NEUTRALIZATION; GP41; EPITOPE; FUSION; 4E10; 2F5; HEMAGGLUTININ; IMMUNIZATION; IMMUNOGENICITY;
D O I
10.1016/j.vaccine.2015.06.072
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Despite significant efforts directed toward research on HIV-1 vaccines, a truly effective immunogen has not been achieved. However, the broadly neutralizing antibodies (BnAbs) 2F5 and 4E10, targeting the highly conserved membrane proximal external region (MPER) of HIV-1, are two promising tools for vaccine development. Here we engrafted the MPER into the linker domain between the trimeric core structure and the transmembrane domain of influenza A virus HA2 to investigate the potential of such chimeric viruses to elicit HIV-1 neutralizing antibodies. In the context of proliferating attenuated influenza A viruses, these HIV-1 neutralizing antibody epitopes could be continuously expressed and mimicked their native conformation to induce humoral immune responses. While MPER-specific antibodies could be detected in serum of guinea pigs vaccinated with the chimeric viruses, they exhibited only weakly neutralizing activities. These antisera from vaccinated animals neutralized viruses of clades B and BC (tier I), but not of clades AE (tier 1) and C (tier 2). These results suggest that influenza A virus can be used as a vehicle for displaying MPER and inducing BnAbs, but it provides limited protection against HIV-1 infection. In the future development of HIV-1 vaccines by rational design, a more effective live virus vector or multiple antigens should be chosen to facilitate the process of neutralizing antibody maturation. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3859 / 3864
页数:6
相关论文
共 50 条
  • [41] Epitope-vaccines: A new strategy to induce high levels of neutralizing antibodies against HIV-1
    Xiao, Y
    Liao, MF
    Lu, Y
    Dierich, MP
    Chen, YH
    IMMUNOBIOLOGY, 2000, 201 (3-4) : 323 - 331
  • [42] Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins
    DeBuysscher, Blair L.
    Scott, Dana
    Marzi, Andrea
    Prescott, Joseph
    Feldmann, Heinz
    VACCINE, 2014, 32 (22) : 2637 - 2644
  • [43] RETRACTED: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER (Retracted Article)
    Han, D.
    Habte, H.
    Qin, Y.
    Takamoto, K.
    LaBranche, C.
    Montefiori, D.
    Cho, M. W.
    RETROVIROLOGY, 2012, 9
  • [44] Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus
    Shibata, R
    Siemon, C
    Czajak, SC
    Desrosiers, RC
    Martin, MA
    JOURNAL OF VIROLOGY, 1997, 71 (11) : 8141 - 8148
  • [45] Modulation of Nonneutralizing HIV-1 gp41 Responses by an MHC-Restricted TH Epitope Overlapping Those of Membrane Proximal External Region Broadly Neutralizing Antibodies
    Zhang, Jinsong
    Alam, S. Munir
    Bouton-Verville, Hilary
    Chen, Yao
    Newman, Amanda
    Stewart, Shelley
    Jaeger, Frederick H.
    Montefiori, David C.
    Dennison, S. Moses
    Haynes, Barton F.
    Verkoczy, Laurent
    JOURNAL OF IMMUNOLOGY, 2014, 192 (04): : 1693 - 1706
  • [46] Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice
    Zhou, Mingkui
    Kostoula, Ioanna
    Brill, Boris
    Panou, Eugenia
    Sakarellos-Daitsiotis, Maria
    Dietrich, Ursula
    VACCINE, 2012, 30 (11) : 1911 - 1916
  • [47] Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens
    Ghorbani, Amir
    Ngunjiri, John M.
    Xia, Ming
    Elaish, Mohamed
    Jang, Hyesun
    Mahesh, K. C.
    Abundo, Michael C.
    Jiang, Xi
    Lee, Chang-Won
    VACCINE, 2019, 37 (10) : 1356 - 1364
  • [48] Interrogating the membrane-proximal external region (MPER) of HIV-1 gp140
    Jeffs, S.
    Durham, N.
    Arias, M.
    Van Roey, G.
    Shattock, R.
    RETROVIROLOGY, 2009, 6
  • [49] Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41
    Zwick, MB
    Labrijn, AF
    Wang, M
    Spenlehauer, C
    Saphire, EO
    Binley, JM
    Moore, JP
    Stiegler, G
    Katinger, H
    Burton, DR
    Parren, PWHI
    JOURNAL OF VIROLOGY, 2001, 75 (22) : 10892 - 10905
  • [50] Generation of Robust Antibody Responses to HIV-1 Membrane Proximal External Region (MPER) Antigens
    Holl, M. T.
    Kuraoka, M.
    Liao, D.
    Verkoczy, L.
    Moody, M. A.
    Alam, S. M.
    Haynes, B.
    Kelsoe, G.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 24 - 25